Twenty four patients with longstanding colonic Crohn's disease were examined prospectively with colonoscopy and multiple biopsy sampling in order to detect histological dysplasia or abnormal aneuploid DNA content, or both. Biopsy specimens were taken from 10 predetermined locations in the colon and rectum. No patient had definite dysplasia but three displayed DNA aneuploidy (12.5%), and one of these subsequently developed a carcinoma (Dukes' C at operation) in the ascending colon. No concomitant dysplasia was detected but the carcinoma as well as other parts of the mucosa were DNA aneuploid. It is concluded that dysplasia is rare in patients with Crohn's colitis, but findings of DNA aneuploidy warrant vigilance in follow up as this may indicate impending carcinoma. Further prospective studies are needed before the predictive value of DNA aneuploidy can be determined and before general recommendations of colonoscopic surveillance, as in longstanding ulcerative colitis, can be made.
Carcinoma development in the colon and rectum complicating longstanding colonic Crohn's disease has been reported in several studies' of patients from large referral centres. Their risk may be significantly increased compared with the general population, but epidemiological data do not support this.56 Only a limited number of patients with Crohn's related colonic carcinoma has been reported so far. In retrospective case reports based on surgical specimens, a varying association between colorectal carcinoma and epithelial dysplasia in Crohn's disease has been reported.7 "0 The need for colonoscopic surveillance programmes, similar to those in longstanding ulcerative colitis, has been suggested. 9 However, there are no prospective studies supporting a dysplasia-carcinoma sequence in Crohn's disease. Recently, a case of Crohn's colitis was reported, where the finding of high grade dysplasia in a macroscopic lesion was associated with an abnormal, aneuploid DNA content." DNA aneuploidy has also been shown in longstanding extensive ulcerative colitis,'2 14 a condition with a verified increase in colorectal carcinoma incidence. '5 In this prospective study, 24 patients with longstanding Crohn's colitis underwent colonoscopy and multiple biopsy sampling according to the surveillance scheme used in longstanding ulcerative colitis. ' No patient had findings of definite dysplasia but DNA aneuploidy was detected in three patients (Table I ). Thus, the crude incidence rate of aneuploidy was 12-5%. The first patient (Fig 1A-D) had DNA aneuploidy detected in the proximal third of the colon at the initial colonoscopy. At colonoscopy two years later neither macroscopic lesions nor histologic dysplasia were detected but unfortunately all 10 biopsy specimens for DNA analyses deteriorated through technical problems. One year later, colonoscopy showed a carcinoma in the ascending colon. At laparotomy, metastatic growth in the lymph nodes was encountered and a right side hemicolectomy with an end to end ileotransversostomy was performed. The carcinoma was staged as Duke's C. Dysplasia was neither found adjacent to nor distant from the carcinoma when the surgical specimen was examined, but the carcinoma as well as the mucosa proximal to the tumour showed DNA aneuploidy. The ploidy level of one of the aneuploid specimens was similar to that detected three years earlier, although there was a notable heterogenicity of the carcinoma with several areas having a normal diploid DNA content. The carcinoma was mainly poorly differentiated with small areas of signet ring cell carcinoma and also with areas with well differentiated colloid adenocarcinoma. The patient was in a quiescent phase of the inflammatory bowel disease with very limited clinical activity. Histological assessment of the colectomy specimen showed moderate inflammatory activity in the ascending colon with a few giant cells and inconspicuous granuloma.
In one other patient (patient 2), who had previously had colectomy and ileosigmoid anastomosis, DNA aneuploidy was detected once in the terminal ileum just proximal to the anastomosis. In the same part of the ileum, changes classified as indefinite, probably positive for dysplasia, were found as well (Fig 2A and B) . However, no abnormal finding was made at a renewed endoscopy one year later. The third patient (Table I) although the predictive value of an aneuploid finding in respect of future development of a manifest carcinoma in these conditions still remains to be determined.
As changes in the DNA content are likely to take place before any histopathological dysplastic changes occur,'6 23 the detection of aneuploidy in mucosal biopsy specimens indicates an increased risk of eventual histological malignant change. The time sequence between the development of aneuploidy and eventual dysplasia or of carcinoma, or both, is unknown, but may be substantial (several years) as illustrated by the first patient in this study. The finding of DNA aneuploidy in this patient was 'predictive' of the subsequent development of a carcinoma three years later. There was neither preceding nor concomitant dysplasia, and as dysplasia seems to be rather rare in colonic Crohn's disease, screening for mucosal DNA aneuploidy may be a more fruitful way to identify high risk patients prone to malignant changes. We still do not know if all patients with DNA aneuploidy will eventually develop a manifest carcinoma.
IS SURVEILLANCE NEEDED IN COLONIC CROHN S DISEASE?
In longstanding extensive ulcerative colitis there is strong evidence of a dysplasia-carcinoma sequence, and the incidence of dysplasia is comparatively high.'624 A dysplasia-carcinoma sequence is not clearly evident in Crohn's disease affecting the large bowel, and the incidence of dysplastic findings seems to be low in large patient groups. These two factors do not favour a surveillance programme based on detection of dysplasia in colonic Crohn's disease. The only marginally increased incidence of colonic carcinoma so far reported is another factor against surveillance. The yield in such a programme would probably be small. However, since the number of patients with longstanding Crohn's colitis may increase during the coming years because of more effective medical treatment and a decreased colectomy rate, a higher proportion of patients with extensive Crohn's colitis may therefore evolve. Thus, the number of patients with an intact colon and long disease duration may become quite substantial. These factors may increase the incidence of colorectal carcinoma in longstanding Crohn's disease, which accordingly will affect the requirements of surveillance programmes. In fact, some authors have already indicated a similar incidence of carcinoma in ulcerative colitis and Crohn's disease. 25 In conclusion, dysplasia is rare in colonic Crohn's disease but findings of DNA aneuploidy in individual patients warrant careful consideration of colectomy. Further prospective trials are needed before any recommendations of surveillance should be issued.
